• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION SMARTSITE NEEDLE-FREE VALVE; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION SMARTSITE NEEDLE-FREE VALVE; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 2000E
Device Problem Fluid/Blood Leak (1250)
Patient Problems Hypoglycemia (1912); No Information (3190)
Event Type  Injury  
Manufacturer Narrative
The affected product has been received and the evaluation is pending.A follow up report will be submitted once the evaluation is completed.
 
Event Description
It was reported that the smartsites are leaking.Product received was "d25", tpn, and lipids.
 
Manufacturer Narrative
Baby.Baby had blood sugar issues.
 
Event Description
It was reported that the needle free valves were leaking.The product received was labeled "d25", tpn, and lipids.Upon identification of the leak, the patient was experiencing a drop in blood sugar.The leaking product could not be ruled out as a cause of the hypoglycemia, although the patient had difficulty maintaining adequate blood sugar levels prior to the leaking event, as well as after the leaking event.The patient was believed to have received unspecified medical intervention for treatment of the low blood sugar.
 
Event Description
It was reported that the needle free valves were leaking.The product received was labeled "d25", tpn, and lipids.Upon identification of the leak, the patient was experiencing a drop in blood sugar.The leaking product could not be ruled out as a cause of the hypoglycemia, although the patient had difficulty maintaining adequate blood sugar levels prior to the leaking event, as well as after the leaking event.It was believed that the patient received unspecified medical intervention for treatment of the low blood sugar.
 
Manufacturer Narrative
The customer¿s report that the needle free valves were leaking was confirmed.No anomalies were noted on the smartsite or set upon initial visual inspection.Functional lab syringe iv push testing identified no leaks at each port or anywhere throughout the sets as they were received on the tifuse extension set.The set was back primed to test for leaks at the smartsite components.Leaks were observed at each of the (3) smartsite component s from the blue piston (b)(4).The root cause of the leak could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMARTSITE NEEDLE-FREE VALVE
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
MDR Report Key8567235
MDR Text Key143991295
Report Number9616066-2019-01205
Device Sequence Number1
Product Code FPA
UDI-Device Identifier07613203011938
UDI-Public7613203011938
Combination Product (y/n)N
PMA/PMN Number
K061285
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 04/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/30/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number2000E
Device Catalogue Number2000E
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/29/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
10839681, THERAPY DATE UNKNOWN
Patient Outcome(s) Required Intervention;
-
-